Literature DB >> 12378518

P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors.

Beverly Y Wang1, Joan Gil, David Kaufman, Li Gan, D Stave Kohtz, David E Burstein.   

Abstract

p63 is a p53-homologous nuclear protein that appears to play a crucial role in regulation of stem cell commitment in squamous and other epithelia. In this study, p63 expression was examined in benign lung and in neoplasms of pulmonary origin. Eighty sections from routinely fixed and processed archival bronchoscopic biopsy or lobectomy specimens were pretreated with citric acid (pH 6.0) for antigen retrieval, then incubated overnight with anti-p63 monoclonal antibody 4A4. Slides were stained using a streptavidin-biotin kit and diaminobenzidine as chromagen, and were counterstained with hematoxylin. In normal lung, p63 intensely stained nuclei of bronchial reserve cells but did not stain ciliated cells, alveolar epithelial cells, or nonepithelial cells. The lower strata of squamous metaplastic bronchial epithelium stained positively. All squamous-cell carcinomas stained positively (n = 30). In some well-differentiated carcinomas, staining was found at the periphery of tumor nests but was negative in central zones showing squamous maturation. Poorly differentiated carcinomas showed very high proportions (80% to 100%) of p63-positive nuclei. All small-cell carcinomas were p63 negative (n = 9). Staining of bronchioloalveolar carcinomas (n = 7) and adenocarcinomas (n = 23) was variable: some tumors showed no detectable staining, others showed heterogeneously positive staining. Adenosquamous carcinomas (n = 5) displayed a unique basalar staining pattern. Carcinoid tumors were almost entirely negative (n = 5). We conclude that p63 is expressed in benign bronchial stem cells, in neoplastic cells with either squamous differentiation or squamous differentiating potential, and in a subpopulation of adenocarcinomas. p63 immunostaining may also aid in some histopathologic distinctions, such as in small biopsies where the differential diagnosis is poorly differentiated squamous carcinoma versus small-cell carcinoma. A stem cell biology-based classification system for squamous carcinomas is proposed. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12378518     DOI: 10.1053/hupa.2002.126878

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  36 in total

1.  Clinicopathological features and immunoexpression profiles of goblet cell carcinoid and typical carcinoid of the appendix.

Authors:  Yong Jiang; Hu Long; Weiya Wang; Huawei Liu; Yuan Tang; Xiuhui Zhang
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

Review 2.  Cervical cancer stem cells.

Authors:  Tingting Yao; Rongbiao Lu; Yizhen Zhang; Ya Zhang; Chenyang Zhao; Rongchun Lin; Zhongqiu Lin
Journal:  Cell Prolif       Date:  2015-12       Impact factor: 6.831

3.  Modulation of TGF-β-inducible hypermotility by EGF and other factors in human prostate epithelial cells and keratinocytes.

Authors:  Wei Wei; Patricia D Barron; James G Rheinwald
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-11-02       Impact factor: 2.416

4.  Adenoid squamous cell carcinoma of the oral cavity.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2012-05-23

Review 5.  The 2011 IASLC/ATS/ERS pulmonary adenocarcinoma classification: a landmark in personalized medicine for lung cancer management.

Authors:  Yong Tang; Zhe He; Qihang Zhu; Guibin Qiao
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

6.  Apolipoprotein E and Periostin Are Potential Biomarkers of Nasal Mucosal Inflammation. A Parallel Approach of In Vitro and In Vivo Secretomes.

Authors:  Youn Wook Chung; Jimin Cha; Seunghan Han; Yong Chen; Marjan Gucek; Hyung-Ju Cho; Kiichi Nakahira; Augustine M K Choi; Ji-Hwan Ryu; Joo-Heon Yoon
Journal:  Am J Respir Cell Mol Biol       Date:  2020-01       Impact factor: 6.914

7.  Squamous and Neuroendocrine Specific Immunohistochemical Markers in Head and Neck Squamous Cell Carcinoma: A Tissue Microarray Study.

Authors:  J S Lewis; R D Chernock; J A Bishop
Journal:  Head Neck Pathol       Date:  2017-05-20

8.  Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update.

Authors:  Dongfeng Tan; Dani S Zander
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

9.  Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray.

Authors:  Jorge S Reis-Filho; Pete T Simpson; Albino Martins; Ana Preto; Fátima Gärtner; Fernando C Schmitt
Journal:  Virchows Arch       Date:  2003-07-16       Impact factor: 4.064

10.  Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients.

Authors:  Jun Araya; Stephanie Cambier; Jennifer A Markovics; Paul Wolters; David Jablons; Arthur Hill; Walter Finkbeiner; Kirk Jones; V Courtney Broaddus; Dean Sheppard; Andrea Barzcak; Yuanyuan Xiao; David J Erle; Stephen L Nishimura
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.